Skip to main content

Table 1 Baseline characteristics of 479 patients with AF-associated FE-IS and TIA (neuroimaging, stroke severity and risk stratification scores)

From: Management of oral anticoagulation after cardioembolic stroke and stroke survival data from a population based stroke registry (LuSSt)

Variable (N*)

Death within 500 days

Survival at 500 days

p-value univariate

p-value multivariate

 

N (%)

    

Gender (479*/479)

   

p=0.31

 

Male

197 (41.1%)

55 (27.9%)

142 (72.1%)

  

Female

282 (58.9%)

92 (32.6%)

190(67.4%)

Age (years) (479*/479)

   

p<0.0001

p=0.001

20-65

44 (9.2%)

3 (6.8%)

41 (93.2%)

  

66-75

105 (21.9%)

18 (17.1%)

87 (82.9%)

76-85

204 (42.6%)

56 (27.5%)

148 (72.6%)

>85

126 (26.3%)

70 (55.6%)

56 (44.4%)

Diagnosis (479*/479)

   

p=0.0001

p=0.95

Ischemic stroke

394 (82.3%)

135 (34.3%)

259 (65.7%)

  

TIA

85 (17.7%)

12 (14.1%)

73 (85.9%)

Neuroradiological Findings (476*/479)

  

Territorial infarction (recent)

256 (53.8%)

99 (38.7%)

157 (61.3%)

p<0.0001

p=0.055

Territorial infarction (old)

45 (9.5%)

15 (33.3%)

30 (66.7%)

p=0.61

 

Hemorrhagic transformation

26 (5.5%)

14 (53.8%)

12 (46.2%)

p=0.01

p=0.46

Hemorrhagic infarction

15 (57.7%)

7 (46.7%)

8 (53.3%)

Parenchymal haematoma

8 (30.8%)

6 (75%)

2 (25%)

Subarachnoidal hemmorh.

3 (11.5%)

1 (33.3%)

2 (66.7%)

Stroke severity

     

NIHSS at admission (461*/479)

  

p<0.0001

p=0.8

0-3

227 (49.2%)

38 (16.7%)

189 (83.3%)

4-8

117 (25.4%)

39 (33.3%)

78 (66.7%)

>9

117 (25.4%)

62 (53%)

55 (47%)

mRS at discharge (470*/479)

  

p<0.0001

p=0.0007

0-1

197 (41.9%)

23 (11.7%)

174 (88.3%)

2-3

123 (26.2%)

38 (30.9%)

85 (69.1%)

>4

150 (31.9%)

85 (56.7%)

65 (43.3%)

Risk stratification score

     

CHA 2 DS 2 -Vasc-Score (452*/479)

  

p=0.0003

 

2-4

30 (6.6%)

2 (6.7%)

28 (93.3%)

  

5

93 (20.6%)

23 (24.7)

70 (75.3%)

6

159 (35.2%)

42 (26.4%)

117 (73.6%)

7

95 (21%)

31 (32.6%)

64 (67.4%)

8-9

75 (16.6%)

35 (46.7%)

40 (53.3%)

HASBLED-Score (458*/479)

  

p<0.0001

 

0-2

115 (25.1%)

18 (15.7%)

97 (84.8%)

3

301 (65.7%)

100 (33.2%)

201 (66.8%)

4

39 (8.5%)

18 (46.2%)

21 (53.6%)

5

3 (0.7%)

2 (66.7%)

1 (33.3%)

  1. *Patients with complete information.
  2. Significant p-values in bold.